Tofacitinib and Iguratimod Combination Shows Promise in PPF Tofacitinib and iguratimod show dual efficacy in controlling synovitis and pulmonary fibrosis, according to a new study.

#Tofacitinib combined with #Iguratimod shows dual efficacy in controlling #Synovitis and #LungFibrosis. Study in Frontiers in Immunology.

Read more: https://bit.ly/4tqBIkB

#RareDisease #Immunology #ProgressivePulmonaryFibrosis

Nutritional Status via CONUT Score Linked to Outcomes in PPF The CONUT score, a simple and low-cost nutritional assessment tool, can help predict disease progression and survival in patients with PPF.

The Controlling Nutritional Status (#CONUT) score, a simple and low-cost nutritional assessment tool, can help predict disease progression and survival in patients with progressive pulmonary fibrosis (#PPF).

Read here: https://bit.ly/4iVmXRW

#RareDisease #ProgressivePulmonaryFibrosis

Antifibrotics Show Potential Benefits in ILD, Despite Low Certainty of Evidence Antifibrotic therapy in ILD may improve patients' QoL by reducing certain symptoms, though the overall certainty of evidence remains limited.

#AntifibroticTherapy in #InterstitialLungDisease, which includes #ProgressivePulmonaryFibrosis (#PPF), may improve patients’ quality of life by reducing certain symptoms, although the overall certainty of evidence remains limited. @tarespirdis.bsky.social

Read more: https://bit.ly/44kikLg

Targeted Approach Identifies Family Members at Risk of Familial PF Genetic testing identified a high prevalence of first-degree relatives potentially at risk of developing interstitial lung disease like PPF.

A dedicated familial pulmonary fibrosis (FPF) service identified a high prevalence of first-degree relatives potentially at risk of developing #InterstitialLungDisease (ILD), including #ProgressivePulmonaryFibrosis (PPF). @btsrespiratory.bsky.social

Learn more: https://bit.ly/48jkImP

#RareDisease

Men With Low Testosterone and f-ILD Exhibit Increased Mortality Risk In the STARSHIP cohort, patients with f-ILD and low testosterone levels had higher mortality even after confounder adjustment.

Low serum #TestosteroneLevels in men with #FibroticInterstitialLungDisease, including #ProgressivePulmonaryFibrosis (PPF), have been associated with an increased risk of mortality compared to patients with normal testosterone levels. @btsrespiratory.bsky.social

Read here: https://bit.ly/3JYsMBk

Pulmonary Rehabilitation Improves Function in Progressive Pulmonary Fibrosis Pulmonary rehabilitation improved exercise endurance and quality of life in patients with progressive pulmonary fibrosis (PPF).

"Pulmonary rehabilitation significantly enhances exercise tolerance + quality of life in patients w #ProgressivePulmonaryFibrosis, according to a meta-analysis of 33 clinical studies involving 1671 individuals w #InterstitialLungDisease" - @rarediseaseadvisor.bsky.social

#PPF #ILD #chronicillness

Pulmonary Rehabilitation Improves Function in Progressive Pulmonary Fibrosis Pulmonary rehabilitation improved exercise endurance and quality of life in patients with progressive pulmonary fibrosis (PPF).

Pulmonary rehabilitation significantly enhances exercise tolerance and quality of life in patients with #ProgressivePulmonaryFibrosis (#PPF), according to a meta-analysis of 33 clinical studies involving 1671 individuals with #InterstitialLungDisease (#ILD).

Read here: https://bit.ly/43pV0v8

Qureight and Avalyn launch strategic partnership in pulmonary fibrosis - PharmaTimes Partnership aims to leverage cutting-edge technology in clinical trials

#Qureight #pulmonaryfibrosis #fibroticlungdiseases #QureightLtd #AvalynPharma #progressivepulmonaryfibrosis #PPF #MISTstudy #AP01 #inhaledpirfenidone #PPFpatients #deeplearning #AI #imagingtechnologies #CoreImagingPlatformtechnology #fibrosis
pharmatimes.com/news/qureigh...